Novo Nordisk presented data at the American Diabetes Association Scientific Sessions held in Chicago.
1 report, 0 independent
Updated Jun 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Novo Nordisk presented data at the American Diabetes Association Scientific Sessions held in Chicago.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Novo Nordisk presented STEP UP trial data at the ADA Scientific Sessions in Chicago, seeking approval for a new oral formulation.Sub-event
- Novo Nordisk presented data at the ADA Scientific Sessions in Chicago.
Keep exploring
Part of
The American Diabetes Association held its Scientific Sessions in Chicago on June 25, 2025.Also in this story
- Ambrosia Biosciences presented clinical data at the American Diabetes Association sessions.
- Skye Bioscience and ISI participated in the American Diabetes Association Scientific Sessions held in Chicago on June 23, 2025.
- Lexicon presented clinical data at the American Diabetes Association sessions.
- Corcept Therapeutics presented data from the CATALYST trial at the American Diabetes Association sessions.
The entities involved
-
Novo Nordisk
Danish pharmaceutical company
-
American Diabetes Association
U.S.-based nonprofit organization
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet